Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease - RegWater

Turku University Hospital0 个研究点目标入组 30 人开始时间: 2013年5月13日最近更新: 2014年1月27日

试验速览

暂无简介。

•One of the following:
•Suspected CAD and referred for cardiac PET perfusion imaging based on clinical indications
•Known CAD and referred for cardiac PET perfusion imaging based on clinical indications
•Patients have been or are referred for coronary angiography, either noninvasive or invasive
•Informed consent from the patient
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 8
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 7

•Continuing, uncontrolled unstable angina symptoms or urgent CABG after invasive coronary angiography
•ST-elevation myocardial infarction (STEMI)
•EF < 40% or diagnosis of cardiomyopathy
•Prior coronary artery bypass grafting (CABG)
•Haemophilia, Von Willebrand's disease or other coagulation disorder
•Severe pulmonary disease
•Symptomatic asthma
•Severe valvular disease
•Uncontrolled hypertension (>180/110 mmHg)
•Moderate to severe renal failure
•Women with childbearing potential
•Age < 18 or > 80 years
•Unstable asthma
•II or III degree AV block or sick sinus syndrome without pacemaker
•Severe hypotension (systolic bloodpressure < 90 mmHg),
•Allergy to x-ray contrast agents (patients have also angiography)

发起方